Skip to main content
辰光医疗 logo

辰光医疗 — Investor Relations & Filings

Ticker · 920300 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2023-12-18 Regulatory Filings
Country CN China
Listing Beijing Stock Exchange 920300

About 辰光医疗

http://www.shanghaicg.net/

Shanghai Chenguang Medical Technologies Co., Ltd. specializes in the research, development, and manufacturing of core components for Magnetic Resonance Imaging (MRI) systems. The product portfolio includes high-performance radiofrequency (RF) coils, superconducting magnets, and gradient coils designed for clinical, preclinical, and veterinary applications. The company focuses on high-field and ultra-high-field MRI technology, providing customized hardware solutions and integrated components to global imaging equipment manufacturers. Its technical capabilities encompass electromagnetic simulation, structural design, and precision manufacturing of specialized imaging hardware.

Recent filings

Filing Released Lang Actions
关于辰光医疗2023年第五次临时股东大会之法律意见书
Regulatory Filings
2023-12-18 Chinese
2023年第五次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement of the resolutions passed at the 2023 fifth extraordinary general meeting of shareholders of Shanghai Chenguang Medical Technology Co., Ltd. It details the meeting date, attendance, agenda items, voting results, and legal opinions confirming the validity of the meeting and resolutions. The content focuses on shareholder meeting decisions and voting outcomes rather than financial results or management reports. The document length is about 3300 characters, which is relatively short and typical for a voting results announcement. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2023-12-18 Chinese
关于股东所持公司股票自愿限售的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding voluntary stock lock-up by shareholders, including details of the number of shares locked, the shareholders involved, and the lock-up period. It does not contain financial statements or performance data but is a regulatory announcement about shareholding restrictions by insiders and management. This fits the category of a Major Shareholding Notification or related shareholding announcement. Given the content focuses on voluntary lock-up of shares by insiders and management, it aligns best with the Major Shareholding Notification (MRQ) category, which covers notifications of changes in significant share ownership or restrictions.
2023-12-10 Chinese
关联交易公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a related party transaction involving a credit facility and guarantee provided by the controlling shareholder. It includes details about the transaction, board approval, independent director opinions, and the need for shareholder meeting approval. The document is short (1448 characters) and focuses on the announcement of the transaction and related approvals rather than providing financial statements or detailed financial analysis. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is not a report publication announcement since it contains substantive information about the transaction itself. The document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement about a related party transaction and board/shareholder approvals, which does not fit more specific categories.
2023-11-29 Chinese
董事会战略与投资委员会工作细则
Governance Information Classification · 95% confidence The document is titled as the "Board of Directors Strategic and Investment Committee Work Rules" of Shanghai Chenguang Medical Technology Co., Ltd. It details the composition, responsibilities, meeting rules, and procedural guidelines of a board committee. There is no financial data, no mention of financial results, no shareholder voting results, no legal proceedings, no capital changes, no executive changes, and no earnings or annual report content. The document is a governance-related internal rules document about the board committee's operation and duties. Therefore, it fits best under Governance Information (CGR). The document length is 2465 characters, which is relatively short but contains substantive governance content, not just an announcement or notice. Hence, it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA).
2023-11-29 Chinese
第五届董事会第六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the sixth meeting of the fifth board of directors of Shanghai Chenguang Medical Technology Co., Ltd. It details meeting attendance, agenda items, voting results, and references to related disclosures on the Beijing Stock Exchange information platform. The content focuses on board meeting decisions, amendments to company rules, business scope changes, credit applications, and notices of upcoming shareholder meetings. There are no financial statements, audit opinions, or earnings data presented. The document is not a full report but an official announcement of board meeting resolutions. Therefore, it fits the category of Board/Management Information (MANG). The document length is 3182 characters, which is relatively short and consistent with a meeting resolution announcement rather than a full report.
2023-11-29 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.